Format

Send to

Choose Destination
Arch Womens Ment Health. 2014 Apr;17(2):167-70. doi: 10.1007/s00737-013-0388-1. Epub 2013 Nov 24.

Managing benzodiazepine withdrawal during pregnancy: case-based guidelines.

Author information

1
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, 3520 Fifth Ave., Keystone Building, Lower Level Suite 1, Pittsburgh, PA, 15213, USA, gopalanpr@upmc.edu.

Abstract

Substance use disorders during pregnancy pose serious risks for both the mother and the fetus, demanding careful monitoring by the patient's medical providers. Sedative-hypnotic use, in particular, is common but remains poorly studied. Management of withdrawal from chronic benzodiazepine use during pregnancy presents unique challenges to the treating physician. We present two pregnant patients with dependence on sedative-hypnotic agents, outline principles of benzodiazepine withdrawal, and suggest guidelines for detoxification during pregnancy.

PMID:
24271083
DOI:
10.1007/s00737-013-0388-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center